Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin
- 1 November 1995
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 39 (11), 2442-2445
- https://doi.org/10.1128/aac.39.11.2442
Abstract
The susceptibilities of 45 strains of Neisseria gonorrhoeae, including 25 strains susceptible to ciprofloxacin (MICs, < or = 0.06 microgram/ml) and 20 strains exhibiting decreased susceptibilities to ciprofloxacin (MICs, > or = 0.125 microgram/ml), to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, norfloxacin, and nalidixic acid were determined by agar dilution and disk diffusion. On the basis of theoretical calculations of predicted susceptibilities at which infections may fail therapy (supported by observed failures of infections to respond to the therapeutic doses of enoxacin and ciprofloxacin), the Centers for Disease Control and Prevention has adopted the following agar dilution breakpoints for interpretation of resistance to these agents: MICs of > or = 1.0 microgram of ciprofloxacin, enoxacin, and norfloxacin per ml and MICs of > or = 2.0 micrograms of ofloxacin and lomefloxacin per ml. The corresponding disk diffusion breakpoints for these agents were as follows: ciprofloxacin, < or = 29 mm; ofloxacin, < or = 24 mm; enoxacin, < or = 31 mm; lomefloxacin, < or = 26 mm; and norfloxacin, < or = 32 mm. The Centers for Disease Control and Prevention recommends two strains as interim quality control strains for susceptibility testing of ciprofloxacin and ofloxacin. These are N. gonorrhoeae CDC-10,328 (MIC of ciprofloxacin, 0.125 to 0.25 microgram/ml [inhibition zone diameter range, 30 to 34 mm]; MIC of ofloxacin, 0.5 microgram/ml [inhibition zone diameter range, 27 to 32 mm]) and N. gonorrhoeae CDC-10,329 (MIC of ciprofloxacin, 1.0 to 2.0 micrograms/ml [zone inhibition diameter range, 21 to 26 mm]; MIC of ofloxacin 2.0 micrograms/ml [inhibition zone diameter range, 18 to 21 mm]).Keywords
This publication has 14 references indexed in Scilit:
- Emerging in vitro resistance to quinolones in penicillinase-producing Neisseria gonorrhoeae strains in HawaiiAntimicrobial Agents and Chemotherapy, 1994
- Persistence of Neisseria gonorrhoeae strains with decreased susceptibilities to ciprofloxacin and ofloxacin in Cleveland, Ohio, from 1992 through 1993Antimicrobial Agents and Chemotherapy, 1994
- High level ciprofloxacin resistance in Neisseria gonorrhoeae.Sexually Transmitted Infections, 1994
- Antimicrobial susceptibilities of Neisseria gonorrhoeae strains representing five distinct resistance phenotypesAntimicrobial Agents and Chemotherapy, 1994
- Reduced uptake of ciprofloxacin in a resistant strain of Neisseria gonorrhoeae and transformation of resistance to other strainsJournal of Antimicrobial Chemotherapy, 1991
- Laboratory detection of ciprofloxacin resistant Neisseria gonorrhoeae.Journal of Clinical Pathology, 1991
- Ciprofloxacin resistance in gonococciThe Lancet, 1990
- Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacinThe Lancet, 1990
- Laboratory Methods for the Detection and Phenotypic Characterization of Neisseria gonorrhoeae Strains Resistant to Antimicrobial AgentsSexually Transmitted Diseases, 1988
- Comparative double-blind study of 200- and 400-mg enoxacin given orally in the treatment of acute uncomplicated urethral gonorrhea in malesAntimicrobial Agents and Chemotherapy, 1987